AYH-23397-81892
2 vaccinations
6 coded responses
25 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 980 / WA
- Registered
- 2021-04-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
8JC-15194-89418
Child or adolescent in my care · Male · 2022-06-26
Timeline
-
2021-04-05
Registered in v-safe
-
2021-04-05
Dose 1 — Pfizer-BioNTech
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-19
-
2021-04-26
Dose 2 — Pfizer-BioNTech
- 2021-04-26
-
2021-04-27
Survey response — days 1–6 daily, dose 2MedDRA: Insomnia — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: InsomniaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Headache, Fatigue or tirednessAdult check-in
-
2021-04-29
Survey response — days 1–6 daily, dose 2MedDRA: Heavy menstrual bleeding — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, DiarrheaFree text: Heavy and lingering menstrationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-30
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain — Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessFree text: Lymph node in armpit painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-01
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-05-03
-
2021-05-10
Survey response — day 14, dose 2MedDRA: Heavy menstrual bleeding, Intermenstrual bleeding — Feeling: GoodFree text: Heavy period and spottingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-06-07
- 2021-07-26
-
2021-10-25
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis, SARS-CoV-2 test — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Had a cold. · Healthcare visit (other): Covid testMedDRA releases: 2024-11 · check-in free text available
-
2021-10-25
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-10-26
-
2022-04-26
Survey response — 12 months, dose 2MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-04-26
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-05 | Pfizer-BioNTech | |
| 2 | 2021-04-26 | Pfizer-BioNTech |
Call center
2 call center cases
2 unsuccessful
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Insomnia
Systemic reaction (other): Heavy and lingering menstration
Systemic reaction (other): Lymph node in armpit pain
Release 8 — day 14, dose 2
Symptoms: Heavy period and spotting
Release 10 — 6 months, dose 2
Release 11 — 12 months, dose 2
Symptoms: Cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | SARS-CoV-2 test | · | · | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Intermenstrual bleeding | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SRO | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release